Artificial Intelligence and Health Technology Assessment: Anticipating a New Level of Complexity.

Journal: Journal of medical Internet research
Published Date:

Abstract

Artificial intelligence (AI) is seen as a strategic lever to improve access, quality, and efficiency of care and services and to build learning and value-based health systems. Many studies have examined the technical performance of AI within an experimental context. These studies provide limited insights into the issues that its use in a real-world context of care and services raises. To help decision makers address these issues in a systemic and holistic manner, this viewpoint paper relies on the health technology assessment core model to contrast the expectations of the health sector toward the use of AI with the risks that should be mitigated for its responsible deployment. The analysis adopts the perspective of payers (ie, health system organizations and agencies) because of their central role in regulating, financing, and reimbursing novel technologies. This paper suggests that AI-based systems should be seen as a health system transformation lever, rather than a discrete set of technological devices. Their use could bring significant changes and impacts at several levels: technological, clinical, human and cognitive (patient and clinician), professional and organizational, economic, legal, and ethical. The assessment of AI's value proposition should thus go beyond technical performance and cost logic by performing a holistic analysis of its value in a real-world context of care and services. To guide AI development, generate knowledge, and draw lessons that can be translated into action, the right political, regulatory, organizational, clinical, and technological conditions for innovation should be created as a first step.

Authors

  • Hassane Alami
    Center for Public Health Research, Université de Montréal, Montreal, Quebec, Canada. hassane.alami@umontreal.ca.
  • Pascale Lehoux
    Center for Public Health Research, Université de Montréal, Montreal, Quebec, Canada.
  • Yannick Auclair
    Institut national d'excellence en santé et services sociaux, Montréal, QC, Canada.
  • Michèle de Guise
    Institut national d'excellence en santé et services sociaux, Montréal, QC, Canada.
  • Marie-Pierre Gagnon
    Research Center on Healthcare and Services in Primary Care, Université Laval, Quebec, QC, Canada.
  • James Shaw
    Department of Internal Medicine, University of Manitoba, Winnipeg, MB, Canada.
  • Denis Roy
    Institut national d'excellence en santé et services sociaux, Montréal, QC, Canada.
  • Richard Fleet
    Department of Family and Emergency Medicine, Université Laval; Québec, QC, Canada; Research Chair in Emergency Medicine Laval University-CHAU Hôtel-Dieu de Lévis Hospital; Lévis City, QC, Canada.
  • Mohamed Ali Ag Ahmed
    Research Chair on Chronic Diseases in Primary Care, Université de Sherbrooke, Chicoutimi, Quebec, Canada.
  • Jean-Paul Fortin
    Research Center on Healthcare and Services in Primary Care, Université Laval, Quebec, Quebec, Canada.